MOTS-c

MOTS-c Peptide Description

MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c) is a naturally occurring 16-amino acid peptide encoded within the mitochondrial genome. It is widely researched for its capacity to restore metabolic homeostasis, improve cellular insulin responsiveness, and ensure mitochondrial stability, especially when the cell is under metabolic strain. Research indicates that the primary mechanism of action for MOTS-c is the activation of the AMPK signaling pathway and other key regulators of metabolic and age-related biological pathways.

MOTS-c Peptide Overview

MOTS-c is a short peptide categorized as a mitochondrial-derived peptide (MDP). These MDPs are now recognized as powerful bioactive signals essential for regulating cellular energy, metabolic control, and communication between organelles. While initially thought to act solely within the mitochondria, current evidence confirms that MOTS-c and related MDPs can move to the cell nucleus and circulate systemically, functioning as endogenous, hormone-like messengers.

As a recently discovered member of this group, MOTS-c has demonstrated diverse biological effects, influencing whole-body metabolism, weight management, exercise capacity, longevity pathways, and skeletal integrity. Its detection in both the nuclear and circulatory systems validates its role as a crucial signaling peptide. Due to its compelling biological activity and therapeutic promise, MOTS-c has rapidly become a major focus in contemporary biomedical research.

MOTS-c Peptide Research

Muscle Metabolism

• Studies in mouse models suggest that MOTS-c is capable of reversing age-related insulin resistance in muscle tissue, thereby significantly enhancing glucose uptake.
• This is achieved through the activation of the AMPK pathway, which boosts skeletal muscle sensitivity and promotes the expression of glucose transporter proteins.
• Crucially, this mechanism operates independently of insulin, offering an alternative route for glucose utilization in contexts of impaired insulin signaling.
• The net effect of MOTS-c includes improved muscle function, support for muscle mass maintenance, and a reduction in insulin resistance.

Fat Metabolism

• Research in animals demonstrates that low estrogen levels are linked to increased fat accumulation and dysfunction of adipose tissue, factors which heighten the risk of insulin resistance and diabetes.
• In contrast, MOTS-c administration in mice has been shown to stimulate brown fat activity (thermogenic fat) and decrease the deposition of white fat. Additionally, the peptide appears to protect against the inflammation and dysfunction of adipose tissue, pathologies intrinsically linked to the onset of insulin resistance.
• A primary pathway through which MOTS-c influences fat metabolism is the activation of the AMPK signaling pathway. Triggered by low cellular energy, this pathway increases the utilization (oxidation) of both glucose and fatty acids for energy production.
• MOTS-c facilitates these metabolic changes by targeting the methionine–folate cycle, increasing AICAR concentrations, and activating AMPK.
• Furthermore, recent findings confirm MOTS-c's ability to exit the mitochondria and enter the nucleus, where it influences nuclear gene expression. In metabolically stressed conditions, MOTS-c has been observed to regulate genes essential for antioxidant defense, energy adaptation, and glucose restriction.

Metabolic Process

Primary Target/Pathway

Key Outcome

Metabolic Health

AMPK Signaling Cascade

Enhanced fuel utilization, improved insulin response

Adipose Tissue Remodeling

Brown Fat Thermogenesis / White Fat Reduction

Reduced adiposity, increased energy expenditure

Lipid Management

Suppresses Specific Lipid Pathways (e.g., Sphingolipid)

Lower systemic fat accumulation in obesity

Skeletal Integrity

Collagen Synthesis in Osteoblasts

Improved bone strength and density

• 
  Experimental evidence from obese mice positions MOTS-c as a central regulator of sphingolipid, monoacylglycerol, and dicarboxylate metabolism. By inhibiting these lipid biosynthetic pathways while promoting beta-oxidation, MOTS-c helps reduce fat accumulation, largely mediated through its activity in the cell nucleus.
• The ongoing research into MOTS-c provides valuable insights into the mechanisms linking fat storage and insulin resistance, suggesting innovative strategies for treating metabolic disorders such as obesity and diabetes.
• A working hypothesis proposes that deficiencies in mitochondrial fat metabolism impede fatty acid oxidation, leading to a surge in circulating lipids. The body reacts by increasing insulin production to clear the excess fat. This long-term compensatory cycle promotes chronic fat buildup and sustained high insulin levels, eventually resulting in clinical insulin resistance.

Insulin Sensitivity

• Studies analyzing MOTS-c levels in human subjects indicate that the correlation between the peptide and insulin sensitivity is strongest in lean individuals.
• This suggests MOTS-c may play a more pivotal role in the initial development of insulin resistance rather than in the long-term, established regulation of the condition.
• Consequently, researchers propose that monitoring MOTS-c levels could serve as an early biomarker for identifying individuals at a heightened risk of prediabetes or insulin resistance.
• Experimental use of MOTS-c supplementation in these vulnerable populations may help delay the onset of insulin resistance and diabetes. While animal data is very positive, additional comprehensive research is required to fully detail the precise mechanisms by which MOTS-c affects human insulin function.

Osteoporosis

• MOTS-c contributes to skeletal health by supporting the synthesis of type I collagen in bone-forming cells known as osteoblasts.
• In vitro studies using osteoblast cell lines confirm that MOTS-c modulates the TGF-beta/SMAD signaling pathway, a critical cascade for osteoblast function and viability.
• By enhancing osteoblast activity, MOTS-c promotes collagen production, thereby improving bone density, strength, and structural integrity.

Article Author

This comprehensive review was written, compiled, and organized by Dr. Changhan Lee, Ph.D., a leading expert in mitochondrial biology and peptide signaling.

Dr. Lee is globally recognized for his pivotal discovery of MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) and his focused research on mitochondrial-derived peptides (MDPs). His scientific contributions at the University of Southern California Leonard Davis School of Gerontology have been foundational in expanding the scientific understanding of how mitochondrial peptides regulate core biological processes, including metabolism, insulin response, and aging.

Scientific Journal Author

The foundational research studies cited in this review were performed by Dr. Changhan Lee, Dr. Pinchas Cohen, and their team of collaborators — including Dr. Kyung Hoon Kim, Dr. Hao Lu, Dr. Jiao Jiao, and Dr. Y. Lin.

Collectively, these scientists have made substantial contributions to the initial identification, characterization, and functional analysis of MOTS-c and related mitochondrial-derived peptides. Their combined work, stemming from institutions such as the University of Southern California, Kyungpook National University, and Peking University, has been published in influential scientific journals, including Cell Metabolism, Nature Communications, and the Journal of Endocrinology.

Reference Citations

• Lee, C. et al. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin re- sistance. Cell Metabolism, 21(3), 443-454.
• Reynolds, J. et al. (2020). Mitochondrial-derived peptides: new frontiers in metabolic signaling. Trends in Endocrinology & Metabolism, 31(2), 101-112.
• Kim, K.H. et al. (2018). MOTS-c suppresses mitophagy in the liver. Nature Communications, 9, 1614.
• Lu, H. et al. (2019). Mitochondrial-derived peptide MOTS-c prevents muscle atrophy by activating AMPK and SIRT1. Aging, 11(15), 4686- 4700.
• Jiao, J. et al. (2021). MOTS-c alleviates insulin resistance in skeletal muscle through enhanced mitochondrial biogenesis. Journal of Endocrinology, 249(3), 243-256.
• Cobb, L. J. et al. (2016). Mitochondrial peptide humanin regulates lifespan and insulin sensitivity. Science Translational Medicine, 8(326), 326ra21.
• Zempo, H. et al. (2016). Mitochondrial-derived peptide MOTS-c: a new player in exercise-induced metabolic improvements. Sports Medicine, 46(7), 965-973.
• Lu, Y. et al. (2021). The role of MOTS-c in muscle aging and sarcopenia. Frontiers in Physiology, 12, 710534.
• Lin, Y. et al. (2022). MOTS-c increases thermogenic activity in brown adipose tissue. Biochemical and Biophysical Research Communications, 590, 101-107.
• Kim, S.J. et al. (2021). Protective effect of MOTS-c on mitochondrial dysfunction in aged mice. GeroScience, 43, 897-909.
• Katsyuba, E. et al. (2020). NAD+ homeostasis in health and disease. Nature Metabolism, 2, 9-31.
• Chen, Y. et al. (2020). MOTS-c ameliorates cognitive decline in a mouse model of aging. Journal of Molecular Neuroscience, 70(3), 358-368.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Storage

Storage Instructions

• All products are manufactured using the lyophilization (freeze-drying) process, which provides stability during shipping for approximately 3-4 months.
• Post-reconstitution with bacteriostatic water, peptides must be stored under refrigeration to maintain effectiveness, with stability lasting up to 30 days.
• Lyophilization, or cryodesiccation, is a specialized technique where peptides are frozen and subjected to low pressure, leading to the sublimation of water (solid to gas). This process leaves behind a stable, white crystalline powder—the lyophilized peptide—that can be safely stored at room temperature until it is reconstituted with bacteriostatic water.
• For extended storage periods, spanning many months to years, it is best to keep peptides in a freezer at -80 degree C (-112 degree F). This temperature range is optimal for preserving the peptide's structural integrity and ensuring long-term stability.
• Upon arrival, peptides should be kept cool and shielded from light. For immediate or short-term use (days to months), refrigeration below 4 degree C (39 degree F) is adequate. Lyophilized peptides generally remain stable at room temperature for several weeks, making this suitable for brief storage.

Best Practices For Storing Peptides

Correct storage is paramount for ensuring the accuracy and reliability of experimental results. Following proper procedures minimizes degradation, oxidation, and contamination, thereby extending the peptide's effective lifespan.

• Peptides should be stored in a cool and light-protected environment immediately upon receipt.
• Short-term storage (days to months) is best achieved through refrigeration below 4 degree C (39 degree F).
• Long-term preservation (months to years) requires storage in a freezer at -80 degree C (-112 degree F) for maximum stability.
• It is crucial to minimize freeze-thaw cycles, as repeated temperature fluctuations accelerate degradation.
• Frost-free freezers should be avoided due to the temperature variations that occur during their automatic defrost cycles, which can compromise peptide stability.

Preventing Oxidation and Moisture Contamination

Protecting peptides from exposure to air and moisture is essential for stability.

• Moisture contamination is a common risk when handling cold peptides. To prevent condensation from forming on the peptide or inside the container, the vial must be allowed to reach room temperature before opening.
• Air exposure must be minimized. The peptide container should be kept closed as much as possible, and promptly resealed after the required amount is removed.
• Storing the remaining peptide under a dry, inert gas atmosphere (e.g., nitrogen or argon) can provide an added layer of protection against oxidation. Peptides containing cysteine (C), methionine (M), or tryptophan (W) residues are particularly susceptible to air oxidation and require meticulous handling.
• To maximize long-term stability, avoid repeated thawing and refreezing. A best practice is to divide the total quantity into smaller, single-use aliquots. This prevents repeated exposure to air and temperature changes.

Storing Peptides In Solution

Peptide solutions have a much shorter shelf life than lyophilized forms and are more vulnerable to bacterial degradation.

• Peptides containing the residues cysteine (Cys), methionine (Met), tryptophan (Trp), aspartic acid (Asp), glutamine (Gln), or N-terminal glutamic acid (Glu) tend to degrade more rapidly when stored in solution.
• If solution storage is necessary, use sterile buffers with a mildly acidic pH (between 5 and 6).
• The solution should be aliquoted to minimize freeze-thaw cycles.
• Under refrigeration at 4 degree C (39 degree F), most peptide solutions are stable for up to 30 days. However, peptides with known instability should be kept frozen when not in immediate use.

Peptide Storage Containers

Containers must be clean, clear, durable, and chemically inert.

• Vials should be appropriately sized to minimize air headspace.
• Both plastic (polystyrene or polypropylene) and high-quality glass vials are suitable options. Glass generally offers superior chemical resistance and stability.
• Peptides are often shipped in plastic to reduce the risk of breakage. They can be safely transferred between container types to meet specific storage or experimental needs.

Peptide Storage Guidelines: General Tips

Adhering to these guidelines is essential for preserving peptide integrity and preventing degradation:

• Store peptides in a cold, dry, and dark environment.
• Avoid repeated freeze-thaw cycles.
• Minimize air exposure to reduce the risk of oxidation.
• Protect peptides from light.
• Store in the lyophilized form long term; avoid prolonged storage in solution.
• Aliquoting is recommended to prevent unnecessary handling and exposure.